Rockwell Automation (ROK) Stock Price Today
Aura AI Summary
Key Stats
- $48.04BMarket Cap
- 947,576Volume
- IndustrialsSector
- $495.0852W High
- $333.7552W Low
- 74 DaysTypical Hold Time
- $51.17BEnterprise Value
- 1.28%Div Yield
- -Trading Activity
Track Rockwell Automation (ROK) stock price today on Pluang, updated in real time with live charts and market data. Over the past 52 weeks, Rockwell Automation has traded between a low of $333.75 and a high of $495.08, highlighting its annual price range. Buy and sell Rockwell Automation shares on Pluang with fractional shares and real-time market data — safe and OJK-regulated.
About Rockwell Automation
Rockwell Automation is a pure-play automation competitor that is the successor entity to Rockwell International, which spun off its former Rockwell Collins avionics segment in 2001. As of fiscal 2021, the firm operates through three segments--intelligent devices, software and control, and lifecycle services. Intelligent devices contains its drives, sensors, and industrial components, software and control contains its information and network and security software, while lifecycle services contains its consulting and maintenance services as well as its Sensia JV with Schlumberger.
Most Recent News
Acoramidis shows 18% lower risk of death and hospitalizations versus tafamidis in real-world ATTR-CM study
Acoramidis, a drug for transthyretin amyloid cardiomyopathy (ATTR-CM), was linked to an 18% lower risk of death, hospitalization, and disease progression compared to tafamidis in a large U.S. electronic health record study of 2,684 patients. The stud...

Stellantis unveils six bold concept cars ahead of the Paris Motor Show, showcasing future mobility and design innovation.
Stellantis revealed six concept cars from its iconic brands at an exclusive event before the Paris Motor Show, highlighting its FaSTLAne 2030 strategy focused on innovation, customer experience, and diverse mobility solutions. These concepts, includi...

New version of Freenome's blood test shows improved detection of advanced precancerous colorectal lesions
Freenome announced improved clinical validation results for its updated SimpleScreen™ CRC blood test, showing an 18.2% sensitivity for advanced precancerous lesions (APLs), up from 13.7% in the original test. Sensitivity for high-grade dysplasia APLs...

People also bought
Frequently Asked Questions
All investments involve risks and the possibility of a loss in investment value. Past performance is not indicative of future results. Historical performance, expected returns, and probability projections are provided for informational and illustrative purposes only.